Top Heart Failure Monitoring Devices Companies Transforming Cardiac Care

Researchers at the University of Glasgow, in May 2024, presented findings from their study of a new heart failure monitoring device, asserting that it could detect fluid overload signs and help prevent hospitalization. The study involving Analog Devices Inc’s Sensinel™ Cardiopulmonary Management System showcased that this device was also able to track fluid changes in patients admitted to hospitals for fluid removal via haemodialysis or decongestion therapy. Such studies are anticipated to support the product development wave in the heart failure monitoring devices industry amid a rise in the morbidity rate associated with heart failure. According to the Centers for Disease Control and Prevention, the U.S. records nearly 6.7 million adults with heart failure in the age group of 20 years and above. Heart failure occurs when the heart cannot pump enough oxygen and blood for supporting other organs in the human body. The use of monitoring devices can help detect changes in heart rhythms and fluid accumulation, enabling adjustments via remote transmission of data and supporting medical action.

Over the past decade, the surging number of cardiac failure cases and associated healthcare costs are pressing the need for effective monitoring solutions across various regions. This has top 10 heart failure monitoring devices companies to develop and bring new advanced solutions for cardiac monitoring. The global market for heart failure monitoring devices is anticipated to hit USD 15.82 billion by 2034 from USD 8.84 billion in 2026, surging at a CAGR of 7.5% over 2026 to 2034, says Fortune Business Insights.

Cardiac Failure Monitoring Devices Landscape: An Account of the Leading Players

Major companies are focusing on digital integration, product innovation, and seeking approval from regulatory bodies to bring their products to the market. Home-based cardiac care solutions is a vital segment gaining attention from industry players. Companies are also emphasizing the development of non-invasive and wearable technologies to cater to the surging device demand.

Here are the top 10 heart failure monitoring devices companies:

1. Abbott

Abbott, based in the U.S., holds a reputation for the development of revolutionary technologies for the healthcare sector and has been a trusted leader in the health tech sector for more than 135 years. One of the company’s major offerings for cardiac failure monitoring is the CardioMEMS HF System. The remote pulmonary pressure monitor aids in tracking the progression of slow heart failure. In February 2026, this device received U.K. ’s NICE (National Institute for Health and Care Excellence) approval, marking its availability for treating chronic heart failure patients within the NHS (National Health Service).

2. Medtronic

Medtronic, headquartered in Ireland, has an extensive portfolio of cardiac rhythm and diagnostics solutions. This heart failure monitoring devices company is a leader in health tech with a portfolio of more than 41,000 active patent matters, as claimed on its website. In October 2025, Medtronic struck a partnership with DASI Simulations for personalizing valve treatment planning decisions and improving predictive heart valve visualization.

3. Boston Scientific Corporation

Boston Scientific Corporation is a renowned developer of innovative technologies in cardiac rhythm management with RESONATE™ Heart Failure Diagnostic, being a significant offering. In October 2025, NICE recommended the company’s HeartLogic™ Heart Failure Diagnostic as a heart failure management option in patients with cardiac implantable electronic devices.

4. Biotronik

Biotronik is known for the development of radiation protection, cardiac rhythm management, neuromodulation, and vascular intervention systems. With headquarters in Germany, the company caters to medical requirements spanning more than 100 countries across Asia, Europe, the Middle East & Africa, and the Americas. In 1963, the company developed Germany’s first pacemaker, and since then, has been depicting an innovative spirit by rolling out new and tech-led solutions. Biotronik announced its BIOMONITOR IV implantable cardiac monitor’s first implant in June 2023. This move marked a significant advancement in the field of cardiac monitoring technology.

5. Koninklijke Philips N.V.

Koninklijke Philips N.V., with headquarters situated in the Netherlands, is known for providing advanced cardiac care solutions. Its portfolio is enriched with solutions in interventional cardiology and monitoring, cardiac imaging, and others. The heart failure monitoring devices player was consecutively chosen as the Clarivate Top 100 Global Innovator^TM for the 13^th year in 2024. In September 2025, Philips launched the Telemetry Monitor 5500 for cardiac monitoring as a data-driven approach for patient care and operational performance enhancement.

6. GE HealthCare

GE Healthcare, one of the top heart failure monitoring devices companies, has a rich portfolio of diagnosis and risk assessment solutions for cardiac care. SIGNA™ Works CV Imaging & Analysis Tools and CARESCAPE™ Monitoring Portfolio are a few of the significant offerings of the U.S.-based company. In December 2023, GE Healthcare entered a commercialization agreement with AirStrip for the exclusive distribution of AirStrip cardiology and patient monitoring solutions in the U.S.

7. ZOLL Medical Corporation

S.-based Zoll Medical Corporation is centered on the development and launch of cardiac care solutions, with Heart Failure Management System* (HFMS) and LifeVest® Wearable Cardioverter Defibrillator (WCD) being some of its pivotal offerings. The company’s Heart Failure Management System* (HFMS) can lower the 90-day hospital readmission rate by 38%, cites JACC Heart Failure. In March 2023, the American College of Cardiology (ACC) released findings from a study involving patients with heart failure wearing the μCor, Zoll’s stick-on sensor. These patients were 38% less likely to be readmitted for heart failure complications within a 90-day period. The system alerts medical professionals in case of fluid accumulation, enabling the effective monitoring of the condition.

8. iRhythm Technologies, Inc.

iRhythm Technologies, Inc., one of the top 10 heart failure monitoring devices companies, provides a range of cardiac monitoring solutions, with emphasis on data-driven insights, accessibility, and precision. The U.S.-based company is focused on innovation and has an advanced FDA-cleared AI in place. Aligning with the same, the company announced a strategic collaboration with Lucem Health in July 2025 for the early acceleration of undiagnosed arrhythmias through a predictive AI solution.

9. Qardio, Inc.

With headquarters located in the U.S., Qardio has cutting-edge Remote Patient Monitoring (RPM) solutions on its portfolio. The heart failure monitoring devices company’s solutions help in the management of several chronic conditions, including cardiovascular diseases and hypertension. An instance is its QardioDirect, an end-to-end RPM (Remote Patient Monitoring) and telehealth service, which was launched in August 2021. The solution helps provide comprehensive care for patients for an extensive range of conditions, including congestive heart failure, hypertension, diabetes, post-surgical care, and others.

10. CardiacSense

Founded in 2012 and situated in Israel, CardiacSense provides solutions for the long-term monitoring of heart arrhythmias, including cardiac arrest or atrial fibrillation. A significant product of the heart failure monitoring devices company is the CardiacSense watch, which provides the self-monitoring of heart conditions. In January 2023, CardiacSense secured the clearance of the U.S. FDA for its CSF-3 Medical Watch for measuring beat-by-beat heart rate, ECG (electrocardiogram), and SpO2 (oxygen saturation of arterial hemoglobin).

Advanced Tech-Integrated Monitoring Devices: The Future of Cardiac Care

In the years to come, heart failure monitoring devices are likely to witness the integration of predictive analytics and artificial intelligence technologies as market players are approaching regulatory bodies to gain approval for their developments. Some of the advanced FDA-cleared offerings, including iRhythm Zio, InfoBionic.Ai MoMe ARC, and AliveCor Kardia 12L, are anticipated to expand their options for cardiac telemetry across healthcare workflows. Experts are also emphasizing the adoption of cloud platforms and AI-enabled analytics for workflow integration, data capture, and data interpretation. Such technologies are likely to prevent the worsening of symptoms by providing early alerts and analyzing patient data.